Nasdaq Caba News Today

Allspring Global Investments Holdings LLC reduced its holdings in Cabaletta Bio, Inc. (NASDAQ:CABA – Free Report) by 71.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,164 shares of the company’s stock after selling 2,972 shares during the quarter. Allspring […]

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 2,152,087 shares changed hands during mid-day trading, an increase of 117% from the previous session’s volume of 991,790 shares.The stock last traded at $10.85 and had previously closed at $11.01. Wall Street Analyst Weigh In A number of […]

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has received an average recommendation of “Buy” from the nine analysts that are covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year […]

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ratings firms that are presently covering the firm, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have updated their coverage on the […]

Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have been given a consensus rating of “Buy” by the nine ratings firms that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on […]

Cantor Fitzgerald restated their overweight rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report published on Friday, Benzinga reports. They currently have a $50.00 price target on the stock. Several other brokerages also recently weighed in on CABA. William Blair restated an outperform rating and set a $38.00 price objective on […]

Cabaletta Bio (NASDAQ:CABA – Get Free Report) and Aptose Biosciences (NASDAQ:APTO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership. Analyst Recommendations This is a breakdown of […]

Jefferies Financial Group assumed coverage on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report report published on Monday morning, MarketBeat reports. The firm issued a buy rating and a $36.00 price target on the stock. A number of other research firms have also commented on CABA. William Blair reiterated an outperform […]

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report)’s share price fell 5.6% during trading on Tuesday . The stock traded as low as $21.22 and last traded at $21.86. 67,430 shares traded hands during mid-day trading, a decline of 91% from the average session volume of 757,777 shares. The stock had previously closed at $23.15. […]

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report)’s stock price rose 7.1% on Thursday . The stock traded as high as $22.08 and last traded at $21.95. Approximately 216,444 shares were traded during trading, a decline of 73% from the average daily volume of 788,854 shares. The stock had previously closed at $20.50. Analyst Ratings […]